Article info

Download PDFPDF
Research paper
Disease-modifying drugs for multiple sclerosis and infection risk: a cohort study

Authors

  1. Correspondence to Dr Helen Tremlett, Medicine (Neurology), University of British Columbia, Vancouver V6T 2B5, Canada; helen.tremlett{at}ubc.ca
View Full Text

Citation

Wijnands JMA, Zhu F, Kingwell E, et al
Disease-modifying drugs for multiple sclerosis and infection risk: a cohort study

Publication history

  • Received October 20, 2017
  • Revised February 26, 2018
  • Accepted March 3, 2018
  • First published March 30, 2018.
Online issue publication 
September 13, 2018

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.